BOS
CVS icon

Bingham Osborn & Scarborough’s CVS Health CVS Stock Holding History

Bingham Osborn & Scarborough’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,570
Closed -$298K – 159
2021
Q2 		$298K Buy
+3,570
New +$292K 0.02% 126
2016
Q3 		– Sell
-2,284
Closed -$219K – 111
2016
Q2 		$219K Sell
2,284
-134
-6% -$13.4K 0.03% 106
2016
Q1 		$251K Sell
2,418
-100
-4% -$9.72K 0.03% 99
2015
Q4 		$246K Sell
2,518
-55
-2% -$5.39K 0.03% 96
2015
Q3 		$248K Hold
2,573
– – 0.03% 94
2015
Q2 		$270K Buy
2,573
+49
+2% +$5.01K 0.03% 94
2015
Q1 		$261K Hold
2,524
– – 0.03% 97
2014
Q4 		$243K Hold
2,524
– – 0.03% 105
2014
Q3 		$201K Buy
+2,524
New +$199K 0.03% 114

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bingham Osborn & Scarborough's CVS Position: Q3 2021 in Review

Bingham Osborn & Scarborough sold out of CVS Health (CVS) in Q3 2021, closing a stake of 3,570 shares — an estimated $298K sold.

Bingham Osborn & Scarborough first reported a position in CVS in Q3 2014 and held it in 9 quarters. The position peaked at $298K in Q2 2021. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Bingham Osborn & Scarborough reported no remaining CVS Health position as of Q3 2021 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 3,570 CVS Health shares in Q3 2021, an estimated $298K.
  • Bingham Osborn & Scarborough first reported a position in CVS Health in Q3 2014 and held it in 9 quarters.
  • Bingham Osborn & Scarborough's CVS Health position peaked at $298K in Q2 2021.
  • 2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Bingham Osborn & Scarborough's 13F filing for Q3 2021, filed 26 Oct 2021.